Spontaneous Left Renal Subcapsular Hematoma and Right Hip Hematoma in a Hemodialysis Patient: A Case Report and Review of the Literature

2016 ◽  
Vol 42 (2) ◽  
pp. 100-103 ◽  
Author(s):  
Muyao Ye ◽  
Yinghong Liu ◽  
Letian Zhou ◽  
Chang Wang ◽  
Xiao Fu ◽  
...  
Keyword(s):  
Molecular Weight ◽  
Case Report ◽  
Low Molecular Weight Heparin ◽  
Hemodialysis Patient ◽  
Maintenance Hemodialysis ◽  
Low Molecular Weight ◽  
Review Of The Literature ◽  
Puncture Site ◽  
Kidney Rupture

For maintenance hemodialysis (MHD) patients, the blood is in low hypercoagulable state due to the use of heparin or low molecular weight heparin during dialysis. It is not rare to see hematoma in the puncture site. In recent years, several cases have been reported of spontaneous kidney rupture, but no hip hematoma, let alone both occurred in succession. There was one MHD patient with spontaneous kidney bleeding and hip hematoma in our hospital in 2014, and we provided effective treatment and follow-up.

Rezidivierende isolierte Unterschenkelmuskelvenenthrombose bei Soleusvenenaneurysma

VASA ◽  
2002 ◽  
Vol 31 (4) ◽  
pp. 277-279 ◽  
Author(s):  
Schwarz ◽  
Zimmermann ◽  
Hänig ◽  
Schröder ◽  
Schellong
Keyword(s):  
Molecular Weight ◽  
Low Molecular Weight Heparin ◽  
Rare Case ◽  
Calf Muscle ◽  
Venous Aneurysm ◽  
Low Molecular Weight ◽  
Therapeutic Dosage ◽  
Follow Up Study ◽  
Short Course

A rare case of venous aneurysm involving the soleal muscle vein in an 18-year-old woman is presented. The patient showed three episodes of ultrasonographically proven calf muscle thrombosis within 2 years. After a short course of low-molecular-weight heparin at a therapeutic dosage, complete thrombus recanalization was achieved. To prevent further thrombotic episodes, surgery including ligation and resection of the aneurysm was performed. At the 3-month follow-up study the patient had completely recovered.

Successful use of low molecular weight heparin in acute oligohydramnios - a case report.

Placenta ◽  
2019 ◽  
Vol 83 ◽  
pp. e100
Author(s):  
Piotr Szkodziak ◽  
Maciej Paszkowski ◽  
Filip Szkodziak ◽  
Piotr Czuczwar ◽  
Sławomir Woźniak ◽  
...  
Keyword(s):  
Molecular Weight ◽  
Case Report ◽  
Low Molecular Weight Heparin ◽  
Low Molecular Weight

scholarly journals Pregnancy with anti-PP1Pk antibody managed with prednisolone and low-molecular-weight heparin – A case report and literature review

2020 ◽  
Vol 27 ◽  
pp. e00238
Author(s):  
Sara Nascimento ◽  
Marta Rodrigues ◽  
Manuel Gonçalves Henriques ◽  
Fernanda Paixão Duarte ◽  
António Barra ◽  
...  
Keyword(s):  
Molecular Weight ◽  
Case Report ◽  
Literature Review ◽  
Low Molecular Weight Heparin ◽  
Low Molecular Weight

Effect of Low Molecular Weight Heparin on Bone Metabolism and Hyperlipidemia in Patients on Maintenance Hemodialysis

2001 ◽  
Vol 24 (7) ◽  
pp. 447-455 ◽  
Author(s):  
K.N. Lai ◽  
K. Ho ◽  
R.C.K. Cheung ◽  
L.C.W. Lit ◽  
S.K.M. Lee ◽  
...  
Keyword(s):  
Molecular Weight ◽  
Lipid Profile ◽  
Bone Metabolism ◽  
Serum Lipid ◽  
Low Molecular Weight Heparin ◽  
Density Lipoprotein ◽  
Lipoprotein Cholesterol ◽  
Maintenance Hemodialysis ◽  
Low Molecular Weight ◽  
Apo B

The effect of low molecular weight heparin (LMWH) on serum lipid profile in hemodialysis remains controversial and its effect on bone metabolism has not been studied. A crossover study was conducted in 40 patients on stable hemodialysis using unfractionated heparin (UFH) for more than 24 months. These patients were then treated with a LMWH (nadroparin-Ca) for 8 months during hemodialysis and subsequently switched back to UFH for 12 months. Serum lipid profile, biochemical markers for bone metabolism, and bone densitometry (BMD) were monitored at four-month intervals while all medications remained unchanged. Cholesterol (TC), triglyceride (TG), low-density lipoprotein-cholesterol (LDL-C), lipoprotein(a) (Lp(a)), apolipoprotein B (Apo B) were raised in 35%, 29%, 12%, 24% and 24% of patients respectively. High-density lipoprotein-cholesterol (HDL-C) and apolipoprotein A1 (Apo A-1) were reduced in 47% and 9% of patients. Bone-specific alkaline phosphatase (BALP) and intact osteocalcin (OSC), both reflecting osteoblastic activity, were raised in 65% and 94% of patients. Tartrate-resistant acid phosphatase (TRACP) reflecting osteoclastic activity and parathyroid hormone (PTH) were elevated in 35% and 88% of patients. Following LMWH treatment, TC, Tg, Lp(a) and Apo B were reduced by 7%, 30%, 21% and 10% respectively (p<0.05 or <0.01) while Apo A-1 were raised by 7% (p<0.01). Simultaneously, TRACP was reduced by 13% (p<0.05). These biochemical changes were detected soon after 4 months of LMWH administration. Although BMD values in our patients were lower than those of age-matched normal subjects, significant changes were not observed with LMWH treatment. After switching back to UFH for hemodialysis, these biochemical indices reverted to previous values during UFH treatment with a significant higher level in TC and Apo B while serum Apo A-1 remained elevated. Our study suggests LMWH may partially alleviate hyperlipidemia and, perhaps, osteoporosis associated with UFH administration in patients on maintenance hemodialysis.

Sign in / Sign up

Export Citation Format

Share Document